We are live on
!
Find out more
OAM
Oberweis Asset Management Portfolio holdings
AUM
$3.39B
1-Year Est. Return
105.5%
This Fund
S&P 500
This Quarter
Est. Return
+8.75%
1 Year Est. Return
+105.5%
3 Year Est. Return
+311.52%
5 Year Est. Return
+632.9%
10 Year Est. Return
+11,604.3%
AUM
$550M
AUM Growth
+$52.4M
(+11%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
3.53%
Top 10 Holdings %
Top 10 Hldgs %
52.39%
Holding
230
New
29
Increased
85
Reduced
59
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$47.5M |
| 2 |
uniQure
QURE
|
+$28.2M |
| 3 |
CACI
CACI
|
+$6.46M |
| 4 |
IPHI
INPHI CORPORATION
IPHI
|
+$4.67M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$4.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$33.8M |
| 2 |
GOOS
Canada Goose Holdings
GOOS
|
+$13.2M |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$8.78M |
| 4 |
CYBR
CyberArk
CYBR
|
+$5.02M |
| 5 |
Ligand Pharmaceuticals
LGND
|
+$4.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.64% |
| 2 | Consumer Staples | 13.57% |
| 3 | Technology | 13.22% |
| 4 | Industrials | 12.46% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
1
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $80.8M | 14.68% |
468,589
+274,689
| +142% | +$47.5M |
|
2
Nomad Foods
NOMD
$1.63B
| $62.9M | 11.42% |
2,943,679
+115,881
| +4% | +$2.43M |
|
3
argenx
ARGX
$57.8B
| $45.6M | 8.28% |
322,000
+15,000
| +5% | +$1.9M |
|
|
4
uniQure
QURE
$2.71B
| $34.6M | 6.29% |
+442,900
| New | +$28.2M |
|
5
Tandem Diabetes Care
TNDM
$1.16B
| $13.9M | 2.53% |
215,920
+24,800
| +13% | +$1.6M |
|
6
DMC Global
BOOM
$126M
| $12M | 2.19% |
190,120
-25,107
| -12% | -$1.67M |
|
7
Champion Homes
SKY
$4.39B
| $9.92M | 1.8% |
362,263
-54,310
| -13% | -$1.24M |
|
8
Vericel Corp
VCEL
$2.3B
| $9.54M | 1.73% |
504,930
+4,260
| +0.9% | +$72.6K |
|
|
HMSY
9
DELISTED
HMS Holdings Corp.
HMSY
| $9.53M | 1.73% |
294,280
+20,530
| +7% | +$628K |
|
10
Skywest
SKYW
$3.82B
| $9.53M | 1.73% |
157,043
-5,414
| -3% | -$321K |
|
11
CareDx
CDNA
$1.94B
| $9.23M | 1.68% |
256,460
+47,250
| +23% | +$1.51M |
|
12
Upland Software
UPLD
$12.4M
| $8.65M | 1.57% |
19,010
+2,771
| +17% | +$1.27M |
|
|
13
CACI
CACI
$10.6B
| $7.6M | 1.38% |
37,150
+32,690
| +733% | +$6.46M |
|
|
CARB
14
DELISTED
Carbonite Inc
CARB
| $7.43M | 1.35% |
285,244
+17,090
| +6% | +$417K |
|
15
Deckers Outdoor
DECK
$13.4B
| $6.75M | 1.23% |
230,160
-41,100
| -15% | -$1.07M |
|
16
Malibu Boats
MBUU
$535M
| $6.74M | 1.22% |
173,468
-11,840
| -6% | -$470K |
|
17
Trex
TREX
$4.4B
| $6.72M | 1.22% |
187,340
+15,920
| +9% | +$540K |
|
|
CSOD
18
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $6.26M | 1.14% |
108,110
+4,430
| +4% | +$240K |
|
19
Alibaba
BABA
$273B
| $6.19M | 1.13% |
36,555
| – | – |
|
20
AtriCure
ATRC
$1.67B
| $6.12M | 1.11% |
204,950
+1,540
| +0.8% | +$45K |
|
|
BAND
21
Bandwidth Inc
BAND
$1.88B
| $6.09M | 1.11% |
81,120
+8,150
| +11% | +$595K |
|
22
Tactile Systems Technology
TCMD
$619M
| $5.99M | 1.09% |
105,140
+3,420
| +3% | +$178K |
|
|
AVTA
23
DELISTED
Avantax, Inc. Common Stock
AVTA
| $5.63M | 1.02% |
185,364
-48,790
| -21% | -$1.61M |
|
|
CCMP
24
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $5.55M | 1.01% |
50,402
-1,558
| -3% | -$176K |
|
|
ALTR
25
DELISTED
Altair Engineering Inc
ALTR
| $5.23M | 0.95% |
129,595
+123,695
| +2,097% | +$4.62M |
|
Similar funds
BG
DFO
VFCM
BCM
MCM
EFM
DIA
5NCM
Oberweis Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, Oberweis Asset Management held 230 positions worth $550M, up 11% from $498M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Oberweis Asset Management deployed $19.4M of net new capital in Q2 2019, opening 29 new positions and adding to 85 existing holdings. Its largest new stake was uniQure: 442,900 shares worth $34.6M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 28% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $4.83M trimmed.
- Oberweis Asset Management's largest Q2 2019 buy was uniQure: 442,900 shares worth $34.6M.
- Oberweis Asset Management added most to GW Pharmaceuticals Plc American Depositary Shares in Q2 2019, an estimated $47.5M increase.
- Oberweis Asset Management's biggest Q2 2019 reduction was Ligand Pharmaceuticals, cutting an estimated $4.83M.
- Oberweis Asset Management fully exited Mellanox Technologies, Ltd. in Q2 2019, selling an estimated $33.8M.
- Oberweis Asset Management's ten largest holdings make up 52% of its $550M portfolio in Q2 2019.
- Oberweis Asset Management opened 29 new positions and closed 34 in Q2 2019.
- Oberweis Asset Management's portfolio value rose 11% quarter-over-quarter to $550M.
Based on Oberweis Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.